Protionamide Cas 14222-60-7

Protionamide (CAS 14222-60-7) Comprehensive Product Guide

Table of Contents

• Basic Information & Specifications
• Clinical Applications
• Therapeutic Agent Comparison
• Clinical Case Studies
• Contact Information

1. Basic Information & Specifications

2. Clinical Applications

Protionamide demonstrates bacteriostatic activity against Mycobacterium tuberculosis, particularly effective in multidrug-resistant tuberculosis (MDR-TB) regimens. Clinical applications include:

• Adjunctive therapy in drug-resistant TB cases
• HIV-associated tuberculosis management
• Latent TB infection treatment in high-risk populations

3. Therapeutic Agent Comparison

4. Clinical Case Studies

Case Study 1: MDR-TB Management

A 38-year-old male with pulmonary MDR-TB demonstrated sputum conversion within 8 weeks using protionamide-containing regimen. Treatment protocol included:

• Protionamide 500mg/day
• Bedaquiline 400mg daily
• Linezolid 600mg daily

Case Study 2: Pediatric Application

12-year-old patient with extrapulmonary TB showed complete resolution of lymph node involvement after 6-month therapy with protionamide dose-adjusted regimen (15mg/kg/day).

5. Contact Information

For technical specifications, clinical data sheets, or procurement inquiries:

Email: info@vivalr.com
Phone: (86) 15866781826